Skip to content
Lower risk Medical device recall · FDA · Published September 5, 2024

Beckman Coulter Access Thyroglobulin Antibody II: False-Low Results Risk

Beckman Coulter recalls Access Thyroglobulin Antibody II (TgAb) assays with incorrect instructions that may cause false-low results. Affected units shipped from July 2021 to current. Contact for remedy.

🇺🇸 FDA recall #Z-0265-2025Medical deviceBeckman Coulter ›
Take action

Contact the company

Recalling firmBeckman Coulter, Inc.1000 Lake Hazeltine Dr · Chaska, MN 55318-1037
✎ GovInfoNow plain-language explainer

Beckman Coulter is recalling Access Thyroglobulin Antibody II tests because their instructions incorrectly state that biotin interference has been fixed. This could lead to false-low results in thyroid antibody tests. The recall affects all units shipped from July 2021 onward. Read more at govinfonow.com/recall/54046-beckman-coulter-access-thyroglobulin-antibody-ii-false-low-results-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/54046-beckman-coulter-access-thyroglobulin-antibody-ii-false-low-results-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0265-2025

Cite this page

“Beckman Coulter Access Thyroglobulin Antibody II: False-Low Results Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/54046-beckman-coulter-access-thyroglobulin-antibody-ii-false-low-results-risk. Based on FDA recall #Z-0265-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0265-2025%22&limit=1).

The FDA announced on Sept. 5, 2024, that Beckman Coulter is recalling Access Thyroglobulin Antibody II kits because their Instructions for Use incorrectly state biotin interference was remediated, potentially causing false-low results. The agency issued recall number Z-0265-2025.

How to tell if you have it

  • Brand: Beckman Coulter
  • Product: Access Thyroglobulin Antibody II, REF A32898
  • IFU Part Numbers: B14994, B63978, and A38168
  • UDI-DI: 15099590202910
  • Distribution: Nationwide to the U.S. (including Puerto Rico) and Mexico; government distribution included

The hazard

The Instructions for Use for the device incorrectly state that biotin interference has been remediated. This error could result in potentially false-low test results.

Context

GovInfoNow's records show Beckman Coulter, Inc. has had 132 other recalls on record since June 20, 2017. Recent similar recalls include the Beckman Coulter DxC 500i Modules recall (July 15, 2026) and the Beckman Coulter MicroScan LabPro V5.03 Panel Update recall (June 26, 2026). Other recent recalls of similar products include the Beckman Coulter Bicarbonate Reagent recall (Oct. 14, 2025), the Roche Elecsys Anti-TSHR Assay recall (Nov. 21, 2025), and the Vivoo Protein Test recall (Nov. 22, 2025).

How to tell if you have this one

Check for the product name 'Access Thyroglobulin Antibody II' with reference number A32898. The instructions for use (IFU) part numbers B14994, B63978, and A38168 apply to all units shipped from July 2021 to current.

  • Brand
    Beckman Coulter
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the product name and reference numbers to confirm if your unit is affected.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Distribution was made nationwide to the U.S., including Puerto Rico. There was government distribution but no military distribution. Foreign distribution was made to Mexico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: Sep 5, 202412. FDA classified it Class II: Oct 30, 202423. Published in FDA’s Enforcement Report: Nov 6, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0265-2025 (September 5, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0265-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA